ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 33 filers reported holding ACLARIS THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $611,000 | -7.3% | 41,994 | +14.7% | 0.00% | – |
| Q3 2021 | $659,000 | -92.2% | 36,600 | -99.0% | 0.00% | -100.0% |
| Q2 2019 | $8,421,000 | -64.9% | 3,845,423 | -4.0% | 0.00% | -69.2% |
| Q1 2019 | $23,989,000 | -18.6% | 4,004,814 | +0.5% | 0.01% | -27.8% |
| Q4 2018 | $29,459,000 | -30.0% | 3,986,422 | +37.5% | 0.02% | -14.3% |
| Q3 2018 | $42,084,000 | -29.1% | 2,898,310 | -2.4% | 0.02% | -30.0% |
| Q2 2018 | $59,321,000 | +31.5% | 2,970,465 | +15.3% | 0.03% | +30.4% |
| Q1 2018 | $45,121,000 | -29.5% | 2,575,391 | -0.8% | 0.02% | -25.8% |
| Q4 2017 | $64,037,000 | +22.2% | 2,596,814 | +27.9% | 0.03% | +19.2% |
| Q3 2017 | $52,417,000 | -1.2% | 2,030,869 | +3.9% | 0.03% | 0.0% |
| Q2 2017 | $53,030,000 | +41.3% | 1,955,381 | +55.4% | 0.03% | +36.8% |
| Q1 2017 | $37,522,000 | -9.5% | 1,258,277 | -17.6% | 0.02% | -9.5% |
| Q4 2016 | $41,457,000 | +3.3% | 1,527,549 | -2.5% | 0.02% | 0.0% |
| Q3 2016 | $40,144,000 | +38.0% | 1,567,513 | -0.5% | 0.02% | +31.2% |
| Q2 2016 | $29,088,000 | -6.4% | 1,574,884 | -3.9% | 0.02% | 0.0% |
| Q1 2016 | $31,067,000 | -30.3% | 1,639,454 | -0.9% | 0.02% | -30.4% |
| Q4 2015 | $44,583,000 | – | 1,654,894 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 1,954,904 | $49,264,000 | 43.26% |
| COMMODORE CAPITAL LP | 1,028,084 | $25,908,000 | 10.32% |
| Foresite Capital Management IV, LLC | 3,399,034 | $85,656,000 | 10.26% |
| VR Adviser, LLC | 3,720,582 | $93,759,000 | 10.17% |
| Parkman Healthcare Partners LLC | 1,709,136 | $43,070,000 | 10.00% |
| Foresite Capital Management V, LLC | 1,258,243 | $31,708,000 | 9.32% |
| Stenahm Asset Managment Ltd | 283,500 | $7,144,000 | 5.04% |
| Samsara BioCapital, LLC | 1,022,612 | $25,770,000 | 4.75% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 336,737 | $8,486,000 | 4.63% |
| Ghost Tree Capital, LLC | 600,000 | $15,120,000 | 3.55% |